BCL2-Related Ovarian Killer (BOK) (N-Term) Peptide
BOK
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN5512172
Quick Overview for BCL2-Related Ovarian Killer (BOK) (N-Term) Peptide (ABIN5512172)
Target
BOK
(BCL2-Related Ovarian Killer (BOK))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- N-Term
-
Sequence
- AAEIMDAFDR SPTDKELVAQ AKALGREYVH ARLLRAGLSW SAPERAAPVP
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-BOK Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BOK (BCL2-Related Ovarian Killer (BOK))
-
Background
-
The protein encoded by this gene belongs to the BCL2 family, members of which form homo- or heterodimers, and act as anti- or proapoptotic regulators that are involved in a wide variety of cellular processes. Studies in rat show that this protein has restricted expression in reproductive tissues, interacts strongly with some antiapoptotic BCL2 proteins, not at all with proapoptotic BCL2 proteins, and induces apoptosis in transfected cells. Thus, this protein represents a proapoptotic member of the BCL2 family.
Alias Symbols: BOK,BCL2L9,
Protein Size: 212 -
Gene ID
- 666
-
NCBI Accession
- XP_005247094
-
UniProt
- Q9UMX3
Target
-
You are here:
